2023
Role of genetics in the development of cardiac allograft vasculopathy
MAYEROVA, Lucie, Anna CHALOUPKA, Peter WOHLFAHRT, Jaroslav Alois HUBACEK, Helena BEDANOVA et. al.Základní údaje
Originální název
Role of genetics in the development of cardiac allograft vasculopathy
Autoři
MAYEROVA, Lucie (203 Česká republika), Anna CHALOUPKA (203 Česká republika, domácí), Peter WOHLFAHRT (203 Česká republika), Jaroslav Alois HUBACEK (203 Česká republika), Helena BEDANOVA (203 Česká republika), Zhi CHEN, Josef KAUTZNER (203 Česká republika), Vojtech MELENOVSKY (203 Česká republika), Ivan MALEK (203 Česká republika), Ales TOMASEK (203 Česká republika), Eva OZÁBALOVÁ (203 Česká republika, domácí), Jan KREJČÍ (203 Česká republika, domácí), Tomas KOVARNIK (203 Česká republika), Milan SONKA (203 Česká republika) a Michal PAZDERNIK (203 Česká republika, garant)
Vydání
Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2023, 0006-9248
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Slovensko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.500 v roce 2022
Kód RIV
RIV/00216224:14110/23:00132170
Organizační jednotka
Lékařská fakulta
UT WoS
000944162900006
Klíčová slova anglicky
cardiac allograft vasculopathy; optical coherence tomography; vascular endothelial growth factor A; intimal thickening; genetic polymorphism
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 1. 2. 2024 12:00, Mgr. Tereza Miškechová
Anotace
V originále
BACKGROUND: The association between genetic polymorphisms and early cardiac allograft vasculopathy (CAV) development is relatively unexplored. Identification of genes involved in the CAV process may offer new insights into pathophysiology and lead to a wider range of therapeutic options.METHODS: This prospective study of 109 patients investigated 44 single nucleotide polymorphisms (SNPs) within the susceptibility loci potentially related to coronary artery disease, carotid artery intima-media thickness (cIMT), and in nitric oxide synthase gene. Genotyping was done by the Fluidigm SNP Type assays and Fluidigm 48.48 Dynamic Array IFC. The intima thickness progression (IT) was evaluated by coronary optical coherence tomography (OCT) performed 1 month and 12 months after heart transplantation (HTx).RESULTS: During the first post-HTx year, the mean intima thickness (IT) increased by 24.0 +/- 34.2 mu m (p < 0.001) and lumen area decreased by -0.9 +/- 1.8 mm2 (p < 0.001). The rs1570360 (A/G) SNP of the vascular endothelial growth factor A (VEGFA) gene showed the strongest association with intima thickness progression, even in the presence of the traditional CAV risk factors. SNPs previously related to carotid artery intima-media thickness rs11785239 (PRAG1), rs6584389 (PAX2), rs13225723 (LINC02577) and rs17477177 (CCDC71L), were among the five most significantly associated with IT progression but lost their significance once traditional CAV risk factors had been added.CONCLUSION: Results of this study suggest that genetic variability may play an important role in CAV development. The vascular endothelial growth factor A gene SNP rs1570360 showed the strongest association with intima thickness (IT) progression measured by OCT, even in the presence of the traditional CAV risk factors (Tab. 3, Fig. 3, Ref. 36). Text in PDF www.elis.sk
Návaznosti
MUNI/A/1410/2022, interní kód MU |
|